申请人:NeuroSearch A/S
公开号:US20010018444A1
公开(公告)日:2001-08-30
Compounds of formula (a), (b), (c), or (d), or any mixture thereof, or a pharmaceutically-acceptable salt thereof;
1
wherein R is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl or 2-hydroxyethyl; R
3
is —CH
2
—X—R′, wherein X is O, S or NR″, wherein R″ is hydrogen or alkyl and R′ is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, or —CO-alkyl; R
4
is phenyl optionally substituted with halogen, CF
3
, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl; 3,4-methylenedioxyphenyl; benzyl optionally substituted with halogen, CF
3
, CH, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl; heteroaryl optionally substituted with halogen, CF
3
, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl; or naphthyl optionally substituted with halogen, CF
3
, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl. The compounds are monoamine neurotransmitter, i.e., dopamine, serotonin, noradrenaline, reuptake inhibitors.
公式为(a),(b),(c)或(d)的化合物,或其任何混合物,或其药学上可接受的盐; 其中R是
氢,烷基,
烯基,炔基,
环烷基,
环烷基烷基或2-羟乙基; R3为-
CH2-X-R',其中X为O,S或NR",其中R"为
氢或烷基,R'为烷基,
烯基,炔基,
环烷基,
环烷基烷基或-CO-烷基; R4为
苯基,可选择用卤素,
CF3,CN,烷
氧基,
环烷氧基,烷基,
环烷基,
烯基,炔基,
氨基,硝基,杂环芳基或芳基取代; 3,4-亚甲二
氧基
苯基;
苄基,可选择用卤素, ,CH,烷
氧基,
环烷氧基,烷基,
环烷基,
烯基,炔基,
氨基,硝基,杂环芳基或芳基取代; 杂环芳基,可选择用卤素, ,CN,烷
氧基,
环烷氧基,烷基,
环烷基,
烯基,炔基,
氨基,硝基,杂环芳基或芳基取代; 或
萘基,可选择用卤素, ,CN,烷
氧基,
环烷氧基,烷基,
环烷基,
烯基,炔基,
氨基,硝基,杂环芳基或芳基取代。这些化合物是单胺神经递质,即
多巴胺,5-羟
色胺,
去甲肾上腺素,再摄取
抑制剂。